India's Richest People 2026 edition · Source: Hurun India
Rank#912- Wealth
- ₹3,200 Cr
- Company
- Shilpa Medicare
2017 #510
Current companies 15 active board seats
Past companies 7 historical roles
Total affiliations 22 Since Jul 1995
Shareholding value •••• Premium profile
About Vishnukanth Chaturbhuj Bhutada
Data last updated:
Vishnukanth Chaturbhuj Bhutada is a Managing Director at Shilpa Medicare Limited (since 2015), Managing Director at Shilpa Pharma Lifesciences Limited (since 2020) and Nominee Director at Shilpa Biologicals Private Limited (since 2020), and holds 12 more current directorships. The companies operate in Pharma, Information Technology and Real Estate and Construction. The 12 current companies with reported revenue have a combined latest revenue of ₹2,302 Cr; the largest is Shilpa Medicare Limited at ₹1,310 Cr (FY 2025). Earlier, Vishnukanth Chaturbhuj Bhutada was a Partner at Auxilla Pharmaceuticals And Research Llp (2020–2023) and Director at Reva Pharmachem Private Limited (2009–2011) and 5 more.
Vishnukant Bhutada and family are #912 among India's richest people (2026), with wealth of ₹3,200 Cr.
DIN 01243391
Primary Designation Managing Director
Industry Pharma
First Appointment 04 Jul 1995
Oldest Company Age 38 yrs
Largest company Shilpa Medicare Limited · ₹1,310 Cr (FY 2025)
Combined revenue ₹2,302 Cr across 12 companies
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shilpa Medicare Limited L85110KA1987PLC008739 | Managing Director | 01 Sep 2015 | 1987 | ₹1,310 Cr (FY 2025) | Active |
| Shilpa Pharma Lifesciences Limited U24100KA2020PLC134081 | Managing Director | 08 May 2020 | 2020 | ₹850 Cr (FY 2025) | Active |
 Shilpa Biologicals Private Limited U24230KA2020PTC131456 | Nominee Director | 09 Jan 2020 | 2020 | ₹85.24 Cr (FY 2025) | Active |
 Ftf Pharma Private Limited U24230GJ2012PTC070818 | Director | 01 Jul 2020 | 2012 | ₹29.49 Cr (FY 2025) | Active |
 Sravathi Advance Process Technologies Private Limited U24299KA2019PTC121993 | Director | 28 Feb 2019 | 2019 | ₹17.29 Cr (FY 2025) | Active |
 Shilpa Therapeutics Private Limited U24239KA2004PTC176079 | Nominee Director | 07 Sep 2011 | 2004 | ₹4.45 Cr (FY 2023) | Active |
 Sravathi Ai Technology Private Limited U24299KA2020PTC134365 | Additional Director | 16 Dec 2025 | 2020 | ₹3.40 Cr (FY 2025) | Active |
| Shilpa Biocare Private Limited U24304KA2020PTC131457 | Nominee Director | 09 Jan 2020 | 2020 | ₹1.28 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 14 Jul 2020 | 2020 | ₹2.52 Cr (FY 2021) | Active | |
 Reva Pharmachem Private Limited U24232KA2009PTC051596 | Director | 23 Nov 2009 | 2009 | Strike Off | |
 Raichem Medicare Private Limited U24232KA2009PTC049999 | Director | 01 Jun 2009 | 2009 | ₹515 Cr (FY 2025) | Active |
 Shilpa Finvest Private Limited U65910MH1995PTC090237 | Director | 04 Jul 1995 | 1995 | Active | |
 Inm Nuvent Paints Private Limited U24110KA2018PTC110829 | Director | 07 Mar 2018 | 2018 | ₹10,000 (FY 2024) | Strike Off |
| Raichem Life Sciences Private Limited U24231TG2007PTC079997 | Director | 01 May 2007 | 2007 | Amalgamated | |
 Inm Technologies Private Limited U73100KA2015PTC078494 | Director | 23 Jan 2015 | 2015 | ₹68.2 Lakh (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vishnukanth Chaturbhuj Bhutada
Directorship timeline
Open interactive timeline →Shilpa Medicare Limited
Inm Nuvent Paints Private Limited
Ftf Pharma Private Limited
Shilpa Biologicals Private Limited
Premium access
Shareholding and investment profile for Vishnukanth Chaturbhuj Bhutada
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishnukanth Chaturbhuj Bhutada
Vishnukanth Chaturbhuj Bhutada currently holds 15 directorships: Shilpa Medicare Limited (Managing Director, since 01 Sep 2015, revenue ₹1,310 Cr (FY 2025)); Shilpa Pharma Lifesciences Limited (Managing Director, since 08 May 2020, revenue ₹850 Cr (FY 2025)); Shilpa Biologicals Private Limited (Nominee Director, since 09 Jan 2020, revenue ₹85.24 Cr (FY 2025)); Ftf Pharma Private Limited (Director, since 01 Jul 2020, revenue ₹29.49 Cr (FY 2025)); Sravathi Advance Process Technologies Private Limited (Director, since 28 Feb 2019, revenue ₹17.29 Cr (FY 2025)); and 10 more.
Vishnukanth Chaturbhuj Bhutada was first appointed on 04 Jul 1995 as Director at Shilpa Finvest Private Limited. The most recent appointment on record is 16 Dec 2025 at Sravathi Ai Technology Private Limited.
The 12 current companies of Vishnukanth Chaturbhuj Bhutada that report revenue have a combined latest revenue of ₹2,302 Cr: Shilpa Medicare Limited ₹1,310 Cr (FY 2025); Shilpa Pharma Lifesciences Limited ₹850 Cr (FY 2025); Shilpa Biologicals Private Limited ₹85.24 Cr (FY 2025); Ftf Pharma Private Limited ₹29.49 Cr (FY 2025); Sravathi Advance Process Technologies Private Limited ₹17.29 Cr (FY 2025); and 7 more.
Vishnukanth Chaturbhuj Bhutada held 7 earlier board appointments: Auxilla Pharmaceuticals And Research Llp (Partner, 14 Jul 2020 to 24 Nov 2023); Reva Pharmachem Private Limited (Director, 23 Nov 2009 to 14 Mar 2011); Raichem Medicare Private Limited (Director, 01 Jun 2009 to 11 Jun 2020); Shilpa Finvest Private Limited (Director, 04 Jul 1995 to 26 Mar 2015); Inm Nuvent Paints Private Limited (Director, from 07 Mar 2018); and 2 more.
The current boards of Vishnukanth Chaturbhuj Bhutada's companies include Alpesh Maheshkumar Dalal (Shilpa Medicare Limited), Anita Bandyopadhyay (Shilpa Medicare Limited), Ashraf Loutfy Abdelhamid Allam (Shilpa Medicare Limited), Hetal Madhukant Gandhi (Shilpa Medicare Limited), Kalakota Reddy Sharath (Shilpa Medicare Limited), Om Prakash Inani (Shilpa Medicare Limited), among others.